Author

L. Bertero

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Organism:mouse· 1

Frequent Co-Authors

A. A. Ricci· 1 shared A. Hernandez-Lain· 1 shared A. Leikin-Frenkel· 1 shared A. Perez-Nunez· 1 shared A. Sacconi· 1 shared A. Schaffer· 1 shared C. Blanco-Aparicio· 1 shared C. Nör· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. A. Ricci

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Inactivation of p53 drives breast cancer brain metastasis by altering fatty acid metabolism

K. Laue, S. Pozzi, Y. Cohen-Sharir, T. Winkler, Y. Eliezer, S. Israeli Dangoor, A. Leikin-Frenkel, K. Lange, J. Zerbib, A. A. Ricci, A. Sacconi, J. Berthelet, A. Schaffer, W. Shi, Y. Liao, , U. Ben-David

This study shows that p53 inactivation promotes breast cancer brain metastasis by altering fatty acid metabolism, with implications for therapeutic targeting.

bioRxiv · Dec 20, 2023 · PreprintCancer Biology

A drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent local relapse and treat established brain metastasis

L. Zhu, N. Yebra, D. Retana, L. Miarka, E. Hernandez-Encinas, C. Blanco-Aparicio, S. Martinez, R. Soffietti, L. Bertero, P. Cassoni, T. Weiss, J. Munoz, J. M. Sepulveda, A. Perez-Nunez, A. Hernandez-Lain, , M. Valiente

The paper introduces a drug-screening platform using organotypic cultures to identify effective treatments for brain metastasis, finding a potent HSP90 inhibitor that works against mouse and human metastases.

bioRxiv · Oct 16, 2020 · PreprintCancer Biology